Lufenuron, the active ingredient in
Program products, is classified as an insect development inhibitor (IDI),
meaning it prevents development in fleas from young stages to the adult
stage. The natural flea life cycle begins as an egg that progresses
into a larva, then a pupa, and finally an adult. Program stops the immature
stages from reaching the adult form. Adult fleas can lay up to 2,000
eggs within their lifetime, easily creating massive infestations.
Program flea control does not require
a veterinary prescription.
Program (lufenuron)
Program for Cats up to 10 lbs. oral
suspension is color-coded orange. It is sold in 6- and 12-packs of individual
135 mg lufenuron doses.
Program for Cats 11-20 lbs. oral suspension
is color-coded green. It is sold in 6- and 12-packs of individual 270
mg lufenuron doses.
Program for Dogs up to 10 lbs. flavor
tablets is color-coded brown. It is sold in 6- and 12-packs of individual
45 mg lufenuron doses.
Program for Dogs 11-20 lbs. and Cats
up to 6 lbs. flavor tablets is color-coded red. It is sold in 6- and
12-packs of individual 90 mg lufenuron doses.
Program for Dogs 21-45 lbs. and Cats
7-15 lbs. flavor tablets is color-coded yellow. It is sold in 6- and
12-packs of individual 204.9 mg lufenuron doses.
Program for Dogs 46-90 lbs. is color-coded
white. It is sold in 6- and 12-packs of individual 409.8 mg lufenuron
doses.
Active ingredients:
Lufenuron
Warnings:
Keep this product out of reach of children
and animals. Do not use or store in or near open flame or heat.
Program products are only for use in
cats and dogs. Do not use in humans or other animals.
Use as directed by your veterinarian.
Program Oral Suspension and Flavor
Tablets do not kill adult fleas. If your treated pet comes into contact
with adult fleas, they can infest your pet. Consult your veterinarian
about concurrent use of a product that kills adult fleas. Capstar tablets
are recommended for this purpose in conjunction with Program Flavored
Tabs.
CAUTION: To prevent flea infestations,
treat all household pets.
Cats treated with Program Oral Suspension
may experience lethargy, depression, diarrhea, vomiting, diminished
appetite, difficulty breathing, itching, or rash. These and hyperactivity
may affect cats treated with Program Flavored Tablets. Similar side
effects, as well as urticaria, may affect dogs treated with Program
Flavored Tablets. Talk to your veterinarian about any adverse effects.
If you know of or suspect an overdose,
seek emergency veterinary care.
Consult your veterinarian before administering
any other medications or supplements concurrently with Program products.
Warranty and Manufacturer Information:
Program for Cats Oral Suspension:
Manufactured for: Novartis Animal Health
US, Inc., Greensboro, NC 27419, USA
NADA # 141-026, Approved by FDA
© 1997 Novartis
NAH/PRO-S/PI/1
6/97
NAC No.: 11310071
Program for Cats and Dogs Flavored
Tablets:
Questions? Comments?
Please call 1-800-332-2761
Visit our website at www.petwellness.com
Manufactured for: Novartis Animal Health
US, Inc., Greensboro, NC 27408
PROGRAM, CAPSTAR, and Flavor Tabs are
registered trademarks of Novartis AG.
NADA # 141-035, Approved by FDA
NADA # 141-205, Approved by FDA
U.S. Patent # 5,750,548
© 2008 Novartis Animal Health US,
Inc.
NAH/PRO-FT/PI/3
2003201
01/08
NAC No.: 11310086